IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO Read More
IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board Read More
Avacta doses first patient in chemotherapy medication trial Read More
IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts Read More
AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down Read More
IN BRIEF: Avacta wins manufacturer certification for lateral flow test Read More
IN BRIEF: Avacta's lateral flow test detects Covid Delta variant Read More
AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs Read More
AIM WINNERS & LOSERS: Mercantile Ports jumps on pact; Avacta recovers Read More
IN BRIEF: Avacta signs distribution deal for its Covid test Read More
UK shareholder meetings calendar - next 7 days Read More
Avacta Covid lateral flow test gets regulatory green light in EU Read More
IN BRIEF: Avacta Covid lateral flow test gets regulatory green light Read More
TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets Read More
Avacta still waiting on response from UK regulator over Covid test Read More
IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days" Read More
Avacta sees Covid-19 tests driving earnings after reporting 2020 loss Read More
IN BRIEF: Avacta's rapid Covid-19 test is 98% sensitive in trial Read More
AIM WINNERS & LOSERS: Warpaint tops outlook; Avacta's Covid test works Read More
UK earnings, trading statements calendar - next 7 days Read More
